{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:59:42Z","timestamp":1792058382595,"version":"4.4.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011652","name":"IISER Mohali","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011652","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific and Engineering Research Board, Department of Science and Technology","award":["DST-IPA\/2021\/00136"],"award-info":[{"award-number":["DST-IPA\/2021\/00136"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To alleviate the contribution of antibody dependent enhancement in DenV pathogenesis, we obtain a DenV neutralizing single domain antibody (sdAb) from an in-house constructed phage display library of camelid VHH. The anti-DenV sdAb specifically reacts with the envelope (E) protein of DenV with a Kd value of 2x108. Molecular dynamic simulations and docking analysis show that the sdAb interacts with the DenV(E) protein via domain II (EDII) and interferes with the virus internalization process. The anti-DenV(E) sdAb potently inhibits the infectivity of a DenV(E) protein expressing pseudovirus as well as that of a virulent DenV in vitro. A mouse adapted DenV2 induces 100% mortality in the infected IFNRKO mice, but the animals injected with the sdAb neutralized virus remain fully protected. Furthermore, the therapeutically administered anti-DenV(E) sdAb slows down the disease progression and enhances the survival of DenV infected animals. In conclusion, we report an anti-DenV(E) sdAb as a potential therapy to manage DenV pathogenesis.<\/jats:p>","DOI":"10.1093\/immhor\/vlaf012","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:29:02Z","timestamp":1743744542000},"source":"Crossref","is-referenced-by-count":3,"title":["In vitro and in vivo neutralization of Dengue virus by a single domain antibody"],"prefix":"10.1093","volume":"9","author":[{"given":"Surbhi","family":"Dahiya","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Indian Institute of Science Education and Research , Manauli, Punjab,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Indian Institute of Science Education and Research , Manauli, Punjab,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav Kumar","family":"Bhati","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Indian Institute of Science Education and Research , Manauli, Punjab,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-6955","authenticated-orcid":false,"given":"Sharvan","family":"Sehrawat","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Indian Institute of Science Education and Research , Manauli, Punjab,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2025040401475699900_vlaf012-B1","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed8010032","article-title":"Increasing dengue burden and severe dengue risk in Bangladesh: an overview","volume":"8","author":"Kayesh","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"2025040401475699900_vlaf012-B2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/tropicalmed7080180","article-title":"Dengue incidence trends and its burden in major endemic regions from 1990 to 2019","volume":"7","author":"Tian","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"2025040401475699900_vlaf012-B3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40259-022-00531-z","article-title":"Dengue vaccines: an update","volume":"36","author":"Torres-Flores","year":"2022","journal-title":"BioDrugs"},{"key":"2025040401475699900_vlaf012-B4","article-title":"Dengue antibody-dependent enhancement: knowns and unknowns","author":"Halstead","journal-title":"MIcrobiol Spectrum. 2014;2:AID-0022"},{"key":"2025040401475699900_vlaf012-B5","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"2025040401475699900_vlaf012-B6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fimmu.2020.01055","article-title":"Challenges in dengue vaccines development: pre-existing infections and cross-reactivity","volume":"11","author":"Izmirly","year":"2020","journal-title":"Front Immunol"},{"key":"2025040401475699900_vlaf012-B7","first-page":"178","article-title":"Dengue vaccine: global development update","volume":"10","author":"Prompetchara","year":"2019","journal-title":"Asian Pac J Allergy Immunol"},{"key":"2025040401475699900_vlaf012-B8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat Med"},{"key":"2025040401475699900_vlaf012-B9","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","volume":"102","author":"Fahimi","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"key":"2025040401475699900_vlaf012-B10","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1073\/pnas.1317350111","article-title":"Dengue virus envelope protein domain I\/II hinge determines long-lived serotype-specific dengue immunity","volume":"111","author":"Messer","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"2025040401475699900_vlaf012-B11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/microorganisms7090323","article-title":"Hijacking the host immune cells by dengue virus: molecular interplay of receptors and dengue virus envelope","volume":"7","author":"Begum","year":"2019","journal-title":"Microorganisms"},{"key":"2025040401475699900_vlaf012-B12","doi-asserted-by":"crossref","first-page":"1200195","DOI":"10.3389\/fimmu.2023.1200195","article-title":"Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement","volume":"14","author":"Sarker","year":"2023","journal-title":"Front Immunol"},{"key":"2025040401475699900_vlaf012-B13","doi-asserted-by":"crossref","first-page":"eabg4084","DOI":"10.1126\/sciadv.abg4084","article-title":"Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies","volume":"7","author":"Kudlacek","year":"2021","journal-title":"Sci Adv"},{"key":"2025040401475699900_vlaf012-B14","doi-asserted-by":"crossref","first-page":"9747549","DOI":"10.1155\/2018\/9747549","article-title":"Evolution of therapeutic antibodies, influenza virus biology, influenza, and influenza immunotherapy","volume":"2018","author":"Chaisri","year":"2018","journal-title":"Biomed Res Int"},{"key":"2025040401475699900_vlaf012-B15","doi-asserted-by":"publisher","first-page":"630307","DOI":"10.3389\/fimmu.2021.630307","article-title":"A mouse model of PPRV infection for elucidating protective and pathological roles of immune cells","volume":"12","author":"Sharma","year":"2021","journal-title":"Front Immunol"},{"key":"2025040401475699900_vlaf012-B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.toxicon.2019.10.240","article-title":"Secretory PLA2 specific single domain antibody neutralizes Russell viper venom induced cellular and organismal toxicity","volume":"172","author":"Kaur","year":"2019","journal-title":"Toxicon"},{"key":"2025040401475699900_vlaf012-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-4-1","article-title":"Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli","volume":"4","author":"S\u00f8rensen","year":"2005","journal-title":"Microb Cell Fact"},{"key":"2025040401475699900_vlaf012-B18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pep.2017.02.007","article-title":"Enhanced expression and purification of camelid single domain VHH antibodies from classical inclusion bodies","volume":"136","author":"Maggi","year":"2017","journal-title":"Protein Expr Purif"},{"key":"2025040401475699900_vlaf012-B19","doi-asserted-by":"publisher","first-page":"104549","DOI":"10.1016\/j.isci.2022.104549","article-title":"Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple vi. Robust anti-SARS-CoV2 single domain antibodies cross neutrali","volume":"25","author":"Singh","year":"2022","journal-title":"iScience"},{"key":"2025040401475699900_vlaf012-B20","doi-asserted-by":"publisher","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"2025040401475699900_vlaf012-B21","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","article-title":"Characterization of a model of lethal dengue virus 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor","volume":"93","author":"Orozco","year":"2012","journal-title":"J Gen Virol"},{"key":"2025040401475699900_vlaf012-B22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2025040401475699900_vlaf012-B23","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4049\/jimmunol.1900142","article-title":"Myeloid-derived suppressor cells confer infectious tolerance to dampen virus-induced tissue immunoinflammation","volume":"203","author":"Sarkar","year":"2019","journal-title":"J Immunol"},{"key":"2025040401475699900_vlaf012-B24","doi-asserted-by":"crossref","first-page":"e1000882","DOI":"10.1371\/journal.ppat.1000882","article-title":"Galectin-9\/TIM-3 interaction regulates virus-specific primary and memory CD8+ T cell response","volume":"6","author":"Sehrawat","year":"2010","journal-title":"PLOS Pathog"},{"key":"2025040401475699900_vlaf012-B25","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"key":"2025040401475699900_vlaf012-B26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"2025040401475699900_vlaf012-B27","doi-asserted-by":"crossref","first-page":"26536","DOI":"10.1038\/srep26536","article-title":"QwikMD\u2014integrative molecular dynamics toolkit for novices and experts","volume":"6","author":"Ribeiro","year":"2016","journal-title":"Sci Rep"},{"key":"2025040401475699900_vlaf012-B28","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J Comput Chem"},{"key":"2025040401475699900_vlaf012-B29","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"2025040401475699900_vlaf012-B30","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J Phys Chem B"},{"key":"2025040401475699900_vlaf012-B31","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"2025040401475699900_vlaf012-B32","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J Chem Phys"},{"key":"2025040401475699900_vlaf012-B33","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1063\/1.470648","article-title":"Constant pressure molecular dynamics simulation: The Langevin piston method","volume":"103","author":"Feller","year":"1995","journal-title":"J Chem Phys"},{"key":"2025040401475699900_vlaf012-B34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"2025040401475699900_vlaf012-B35","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(16)00026-8","article-title":"The global burden of dengue: an analysis from the Global Burden of Disease Study 2013","volume":"16","author":"Stanaway","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2025040401475699900_vlaf012-B36","first-page":"1831","article-title":"Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art","volume":"104","author":"Pintado","year":"2023","journal-title":"J Gen Virol"},{"key":"2025040401475699900_vlaf012-B37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/22221751.2021.2021808","article-title":"Generation and characterization of genetically and antigenically diverse infectious clones of dengue virus serotypes 1\u20134","volume":"11","author":"Tamura","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"2025040401475699900_vlaf012-B38","doi-asserted-by":"crossref","first-page":"e1188","DOI":"10.1371\/journal.pntd.0001188","article-title":"In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection","volume":"5","author":"de Alwis","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2025040401475699900_vlaf012-B39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/vbz.2007.0117","article-title":"Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigens","volume":"8","author":"Lazaro-Olan","year":"2008","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"2025040401475699900_vlaf012-B40","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1038\/emi.2016.74","article-title":"Vaccines and immunization strategies for dengue prevention","volume":"5","author":"Liu","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"2025040401475699900_vlaf012-B41","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/21645515.2015.1126012","article-title":"Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naive vaccinees","volume":"12","author":"Velumani","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2025040401475699900_vlaf012-B42","doi-asserted-by":"crossref","first-page":"621043","DOI":"10.3389\/fimmu.2020.621043","article-title":"Landscape of monoclonal antibodies targeting zika and dengue: therapeutic solutions and critical insights for vaccine development","volume":"11","author":"Dussupt","year":"2020","journal-title":"Front Immunol"},{"key":"2025040401475699900_vlaf012-B43","doi-asserted-by":"crossref","first-page":"e1010469","DOI":"10.1371\/journal.ppat.1010469","article-title":"Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model","volume":"18","author":"Tien","year":"2022","journal-title":"PLoS Pathog"},{"key":"2025040401475699900_vlaf012-B44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/mabs.1.2.7908","article-title":"Monoclonal antibody to dengue capsid protein: its application in dengue studies","volume":"1","author":"Vazquez","year":"2009","journal-title":"MAbs"},{"key":"2025040401475699900_vlaf012-B45","doi-asserted-by":"publisher","first-page":"581076","DOI":"10.3389\/fimmu.2020.581076","article-title":"Perspective: reducing SARS-CoV2 infectivity and its associated immunopathology","volume":"11","author":"Dubey","year":"2020","journal-title":"Front Immunol"},{"key":"2025040401475699900_vlaf012-B46","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.7150\/thno.57510","article-title":"Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice","volume":"11","author":"Xenaki","year":"2021","journal-title":"Theranostics"},{"key":"2025040401475699900_vlaf012-B47","doi-asserted-by":"crossref","first-page":"1005800","DOI":"10.3389\/fimmu.2022.1005800","article-title":"Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors","volume":"13","author":"Hambach","year":"2022","journal-title":"Front Immunol"},{"key":"2025040401475699900_vlaf012-B48","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fonc.2020.01182","article-title":"Nanobodies: next generation of cancer diagnostics and therapeutics","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"2025040401475699900_vlaf012-B49","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1128\/JVI.02957-12","article-title":"Structure of a dengue virus envelope protein late-stage fusion intermediate","volume":"87","author":"Klein","year":"2013","journal-title":"J Virol"},{"key":"2025040401475699900_vlaf012-B50","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1073\/pnas.1332695100","article-title":"Dengue virus envelope glycoprotein structure: new insight into its interactions during viral entry","volume":"100","author":"Rey","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"2025040401475699900_vlaf012-B51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope glycoprotein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"2025040401475699900_vlaf012-B52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/ijms19010054","article-title":"Development of antibody therapeutics against Flavivirus","volume":"19","author":"Sun","year":"2017","journal-title":"Int J Mol Sci"}],"container-title":["ImmunoHorizons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/9\/5\/vlaf012\/62857860\/vlaf012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/9\/5\/vlaf012\/62857860\/vlaf012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:30:23Z","timestamp":1743744623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article\/doi\/10.1093\/immhor\/vlaf012\/8105731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,3,26]]}},"URL":"https:\/\/doi.org\/10.1093\/immhor\/vlaf012","relation":{},"ISSN":["2573-7732"],"issn-type":[{"value":"2573-7732","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,3,26]]},"article-number":"vlaf012"}}